Dolby Laboratories, Inc.DLBNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +4.90% | +13.13% | +1.38% | +9.25% | +0.73% |
| Gross Profit Growth | +6.20% | +11.54% | +2.45% | +7.26% | -1.22% |
| EBITDA Growth | +152.68% | +9.29% | +1.51% | +0.17% | -28.22% |
| Operating Income Growth | +66.28% | +17.68% | +5.17% | +16.59% | -34.14% |
| Net Income Growth | +537.60% | +1.26% | -6.17% | +19.84% | -15.77% |
| EPS Growth | +510.00% | +1.43% | -6.86% | +20.00% | -14.75% |
| EPS Diluted Growth | +577.78% | +1.45% | -6.93% | +20.00% | -16.39% |
| Weighted Average Shares Growth | -0.32% | +0.25% | +0.64% | +0.22% | +0.25% |
| Weighted Average Shares Diluted Growth | -1.11% | -0.30% | +0.63% | -0.06% | +0.26% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +36.65% | +1169.82% | -3.59% | +218.34% | +5.73% |
| Free Cash Flow Growth | +41.60% | +4229.00% | -2.60% | +348.78% | -7.17% |
| Receivables Growth | +0.00% | +9.67% | +3.65% | +5.32% | +0.00% |
| Inventory Growth | +0.00% | -15.27% | -3.36% | -6.63% | +0.00% |
| Asset Growth | +0.00% | +7.60% | +6.05% | +7.48% | +0.00% |
| Book Value per Share Growth | +0.00% | +6.64% | +5.64% | +6.83% | +0.00% |
| Debt Growth | +0.00% | -5.92% | -22.12% | -18.84% | +0.00% |
| R&D Expense Growth | -2.54% | -0.59% | -1.26% | +0.73% | -1.71% |
| SG&A Expenses Growth | -0.24% | +14.10% | +2.08% | +7.95% | +4.54% |